surmount-1 tirzepatide non-diabetic obesity weight loss 💊 Could a new medication help reduce complications of obesity? The SURMOUNT-MMO trial investigates tirzepatide, a dual GIP and GLP-1 receptor agonist, in adults with or overweight but without diabetes. Researchers Frontiers | Tirzepatide against obesity

This is just for reference, as this article focuses specifically on the brand-name drug Victoza compared to Jardiance

I'm trying to get ahead of my condition by learning more about the latest research and drugs available." "I've been diagnosed with type 2 diabetes since 2000

Whether the market looks past that in the short termId say not

The SURPASSCVOT kidney analysis positions tirzepatide as a promising agent capable of delivering both metabolic and renal benefits beyond established GLP1 therapy

The idea behind these shots is that they help the body break down fat more efficiently, boost metabolism, and increase energy levels, potentially aiding in weight loss

Treat this as a research summary, not a guide to expected outcomes